Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
18.38
+0.14 (0.77%)
At close: Apr 28, 2025, 4:00 PM
18.10
-0.28 (-1.52%)
Pre-market: Apr 29, 2025, 8:16 AM EDT

Innoviva Market Cap

Innoviva has a market cap or net worth of $1.15 billion as of April 29, 2025. Its market cap has increased by 24.04% in one year.

Market Cap
1.15B
Enterprise Value
1.26B
1-Year Change
24.04%
Ranking
Category
Stock Price
$18.38

Market Cap Chart

Since October 5, 2004, Innoviva's market cap has increased from $743.40M to $1.15B, an increase of 55.20%. That is a compound annual growth rate of 2.16%.

History

DateMarket Cap% Change
Apr 28, 20251.15B6.07%
Dec 31, 20241.09B5.65%
Dec 29, 20231.03B11.18%
Dec 30, 2022924.60M-22.87%
Dec 31, 20211.20B-4.58%
Dec 31, 20201.26B-12.40%
Dec 31, 20191.43B-18.66%
Dec 31, 20181.76B15.03%
Dec 29, 20171.53B31.74%
Dec 30, 20161.16B-6.00%
Dec 31, 20151.24B-24.18%
Dec 31, 20141.63B-48.60%
Dec 31, 20133.18B81.10%
Dec 31, 20121.75B15.68%
Dec 30, 20111.52B16.20%
Dec 31, 20101.30B94.91%
Dec 31, 2009669.40M8.40%
Dec 31, 2008617.50M-35.48%
Dec 31, 2007957.00M-35.96%
Dec 29, 20061.49B30.34%
Dec 30, 20051.15B49.85%
Dec 31, 2004765.10M2.92%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 782.51B
UnitedHealth Group 380.40B
Johnson & Johnson 373.16B
AbbVie 339.20B
Novo Nordisk 272.76B
Abbott Laboratories 224.48B
AstraZeneca 218.53B
Novartis AG 211.71B
Market Cap Rankings